Cargando…

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Pastorino, U, Silva, M, Sestini, S, Sabia, F, Boeri, M, Cantarutti, A, Sverzellati, N, Sozzi, G, Corrao, G, Marchianò, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Errata
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857602/ https://www.ncbi.nlm.nih.gov/pubmed/31168572 http://dx.doi.org/10.1093/annonc/mdz169

Ejemplares similares

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
por: Pastorino, U, et al.
Publicado: (2019)

Inflammatory status and lung function predict mortality in lung cancer screening participants
por: Pastorino, Ugo, et al.
Publicado: (2018)

Feasibility and Safety of Lung Cancer Screening and Prevention Program During the COVID-19 Pandemic
por: Milanese, Gianluca, et al.
Publicado: (2021)

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
por: Sestini, Stefano, et al.
Publicado: (2015)

Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
por: Sestini, Stefano, et al.
Publicado: (2019)

Fully automated calcium scoring predicts all-cause mortality at 12 years in the MILD lung cancer screening trial
por: Sabia, Federica, et al.
Publicado: (2023)

Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval
por: Silva, Mario, et al.
Publicado: (2020)

Volumetric Measurements in Lung Cancer Screening Reduces Unnecessary Low-Dose Computed Tomography Scans: Results from a Single-Center Prospective Trial on 4119 Subjects
por: Milanese, Gianluca, et al.
Publicado: (2022)

Automated Coronary Artery Calcium and Quantitative Emphysema in Lung Cancer Screening: Association With Mortality, Lung Cancer Incidence, and Airflow Obstruction
por: Balbi, Maurizio, et al.
Publicado: (2023)

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations()
por: Hu, Jiangting, et al.
Publicado: (2015)

Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality
por: Silva, Mario, et al.
Publicado: (2017)

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers
por: Verri, Carla, et al.
Publicado: (2017)

Lung cancer screening
por: Pastorino, U
Publicado: (2010)

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England
Publicado: (2010)

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
por: Mensah, Mavis, et al.
Publicado: (2017)

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
por: Fortunato, Orazio, et al.
Publicado: (2022)

Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis
por: Milione, Massimo, et al.
Publicado: (2020)

Routine perioperative blood tests predict survival of resectable lung cancer
por: Morelli, Daniele, et al.
Publicado: (2023)

Erratum: “Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis”
Publicado: (2014)

Distribution of nuchal translucency in antenatal screening for Down's syndrome
Publicado: (2010)

Erratum: Attenuation of Lipopolysaccharide-induced Lung Vascular Stiffening by Lipoxin Reduces Lung Inflammation
Publicado: (2021)

Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting
por: Montomoli, Emanuele, et al.
Publicado: (2021)

Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients
por: Fortunato, Orazio, et al.
Publicado: (2014)

Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres
Publicado: (1996)

Erratum to “eComment. Does adrenalectomy in lung cancer improve survival? [Interact CardioVasc Thorac Surg 2014;18(4):497–498](†)”
por: Cubuk, Sezai, et al.
Publicado: (2015)

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small cell lung cancer (SCLC) and poor prognosis
Publicado: (1996)

Evaluation of Simplified Diet Scores Related to C-Reactive Protein in Heavy Smokers Undergoing Lung Cancer Screening
por: Sabia, Federica, et al.
Publicado: (2022)

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction
por: Fortunato, O, et al.
Publicado: (2014)

Erratum for Investigation of blood biomarkers for the diagnosis of mild to moderate asthma in horses
Publicado: (2019)

Erratum: Prolonged monitoring of cerebral blood flow and autoregulation with diffuse correlation spectroscopy in neurocritical care patients
por: Selb, Juliette, et al.
Publicado: (2020)

Erratum. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A(1c) Testing. Diabetes Care 2019;42:576–584
por: Evron, Joshua M., et al.
Publicado: (2020)

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy
por: Apolone, Giovanni, et al.
Publicado: (2020)

Erratum: Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients
por: Yanai, Hagai, et al.
Publicado: (2015)

Erratum: “Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization”
Publicado: (2023)

Towards automatic pulmonary nodule management in lung cancer screening with deep learning
por: Ciompi, Francesco, et al.
Publicado: (2017)

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature
por: Fortunato, Orazio, et al.
Publicado: (2016)

Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas
Publicado: (1998)

Corrigendum: Towards automatic pulmonary nodule management in lung cancer screening with deep learning
por: Ciompi, F., et al.
Publicado: (2017)

Screening for Lung Cancer — 10 States, 2017
por: Richards, Thomas B., et al.
Publicado: (2020)

Völker LA, Kaufeld J, Miesbach W, et al. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood Adv. 2020;4(13):3085-3092.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_toc5ottga5giajfoa3lbvdf1pl